Patients with missense or truncating variants in TRIO that reduce GEF1 activity have mild developmental delay and microcephaly (Barbosa et al., 2020; Bonnet et al., 2023; Pengelly et al., 2016; Bircher et al., 2022). This evidence concerns the gene ARHGEF1 and Global developmental delay.